

Cover Story
JudiciaryNews Analysis
By Matthew Bin Han Ong
The Supreme Court last week upended one of the underpinnings of administrative law by weakening the authority of federal health agencies to rely on technical expertise as they regulate medical products, issue coverage decisions, and respond to public health crises.
In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for July 2024
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Duke brain cancer researcher Kyle Walsh named director of NIEHS
















